Corey Rosen
ESOP Valuation Case Against Envision Radiology Can Proceed
In Harrison v. Envision Management Holding Company, No. 22-1098 (D. Colo. Mar. 21, 2024), a district court said that plaintiffs had pleaded sufficient allegations to allow a case concerning the price paid by an ESOP for Envision Radiology to continue. Envision was sold to an ESOP in 2017. The ESOP paid $163.7 million to the sellers. Plaintiffs allege the ESOP paid $1,770 per share for 64% of the Envision shares and $1,404 per share for 36% of the Envision shares, but that there was no reason for the discrepancy. The defendants argued this was incorrect. The stock dropped to $349 after the transaction (the deal was financed with debt, so the stock price would normally decline). The judge ruled that at this stage, there were voluminous filings to review, and that it was premature to dismiss the case.